Fundraising FoxNew View Surgical
Boston, US · Delaware corporation · 7 known investors
Find your way into New View Surgical
Sign up to see every warm intro you have to New View Surgical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the New View Surgical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures. The company targets healthcare systems seeking to reduce costs while improving clinical outcomes.
Founders & leadership
BK
Bryce KlontzExecutive
MB
Melvin B. PrenovitzNamed on SEC filing
Board
MH
NB
Nancy BriefsBoard director
SF
Scott FloraBoard director
Investors · 7
AEON Foundrylisted by AEON FoundryNew York City
How we know: AEON Foundry's portfolio page · Not right? Tell us
Arieal Southeast Angel Partnerslisted by Arieal Southeast Angel PartnersSavannah · $100K – $2M
How we know: Arieal Southeast Angel Partners's portfolio page · Not right? Tell us
IAG Capital PartnersreportedCharleston
How we know: press coverage · Not right? Tell us
Keiretsu ForumreportedSan Francisco East Bay · $250K – $2M
How we know: press coverage · Not right? Tell us
New York AngelsreportedNew York · $100K – $1.5M
How we know: press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$15.8M disclosed across 4 of 5 rounds · 2017–2022
- Undisclosed amountSeries AJun 2019Source ↗
▶$7MraisedSep 2022 · 11 investors · Other TechnologyRule 506(b)
▶$7MraisedSep 2022 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Scott FloraDirector
- Bryce KlontzExecutive Officer, Director
- Nancy BriefsDirector
- John YoungerDirector
- Melvin B. PrenovitzExecutive Officer, Director
- Mark H. SchneiderDirector
- Thomas TestaDirector
- Offering amount
- $10M
- Amount sold
- $7M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedSep 2021 · 48 investors · Other TechnologyRule 506(b)
▶$5.6MraisedSep 2021 · 48 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Bryce KlontzExecutive Officer, Director
- Mark H. SchneiderDirector
- Nancy BriefsDirector
- Melvin B. PrenovitzExecutive Officer, Director
- John YoungerDirector
- Scott FloraDirector
- Thomas TestaDirector
- Offering amount
- $9M
- Amount sold
- $5.6M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedApr 2021 · 52 investors · Other TechnologyRule 506(b)
▶$2.1MraisedApr 2021 · 52 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark H. SchneiderDirector
- Melvin B. PrenovitzExecutive Officer, Director
- Nancy BriefsDirector
- Scott FloraDirector
- Bryce KlontzExecutive Officer
- Offering amount
- $2.8M
- Amount sold
- $2.1M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedNov 2017 · 39 investors · Other TechnologyRule 506(b)
▶$1.1MraisedNov 2017 · 39 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Melvin B. PrenovitzExecutive Officer, Director
- Bryce KlontzExecutive Officer
- Arthur C. McKinleyExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $1.1M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
NviewmednView medical develops the nView s1, a low-dose 3D imaging and surgical navigation system with true-map navigation and AI-based intraoperative planning, guidance, and quality control. The system is designed for pediatric and adult surgery, used by children's hospitals and surgical teams.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Current SurgicalCurrent Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.
Companies working in the same space as New View Surgical.
In the news
Frequently asked questions
- What does New View Surgical do?
- New View Medical develops single-use surgical visualization devices designed for minimally invasive procedures. The company targets healthcare systems seeking to reduce costs while improving clinical outcomes.
- Who are New View Surgical's investors?
- New View Surgical's investors include AEON Foundry, Arieal Southeast Angel Partners, Crimson Investment Fund, IAG Capital Partners, Keiretsu Forum, New York Angels, NYA 2021.
- How much funding has New View Surgical raised?
- New View Surgical has disclosed $15.8M raised across 4 of its 5 known rounds.
- Where is New View Surgical headquartered?
- New View Surgical is headquartered in Boston, US.